From 1 October 2021, Australians will require a prescription to legally access e-cigarettes containing nicotine (e-cigarettes), liquid nicotine, and other novel nicotine delivery products, such as heat-not-burn tobacco products. Read about the Therapeutic Goods Administration’s decision about e-cigarettes and what this means for prescribers.
Review practical recommendations from Australian diabetes experts on when and how to use IDegAsp (insulin degludec/insulin aspart) in real-world practice.
This series of podcasts aims to provide general practitioners (GPs) and other healthcare professionals with the latest clinically relevant information and opinions from experts in T2DM about the appropriate management of patients with T2DM in primary care, particularly regarding insulin therapy.
Strong steps in osteoporosis: Learning a step-wise approach to identifying and preventing osteoporotic fracture
This module takes participants though a step-wise model which helps identify patients at risk of osteoporotic fracture, and looks at strategies for prevention and ongoing management.
This education module focuses on a case study of an uncomplicated patient with type 2 diabetes, and the process of intensifying to first injectable therapy. Expert video commentary throughout the module helps step the participant through the decision cycle from the ADA/EASD consensus guidelines for T2D. This module also includes Australian recommendations for patients fasting during Ramadan.
In this education module, the participant will work through a case study of a type 2 diabetes patient with ASCVD risk factors. The case study uses the decision cycle from the ADA/EASD consensus guidelines for T2D, and features expert video commentary. The module also discusses patient-related concerns leading to clinical inertia, including useful management decisions when faced with this issue.
This education module takes a case-study based look at the management of a type 2 diabetes patient with established ASCVD. Featuring expert video commentary, participants will use the decision cycle from the ADA/EASD consensus guidelines for T2D to work through a hypothetical case study. This module also discusses GP-related causes of clinical inertia, as well as additional patient factors such as obesity, low health literacy and diabetes distress.
By 2022, it is estimated that 6.2 million Australians older than 50 years of age will have osteoporosis or osteopenia, placing them at high risk of minimal trauma fracture. This program aims to support identification, evaluation and treatment of patients at high risk of osteoporotic fracture.